Michael J. Fox appears on The Oprah Winfrey Show

foxonoprahwinfreyMarch 31, 2009 – Actor/advocate Michael J. Fox appeared as a guest on Oprah Winfrey’s show on Tuesday to talk about his life with Parkinson’s disease, his upcoming book, and advancements being made in Parkinson’s research.

In 1991, Fox was diagnosed with Parkinson’s Disease and forced to semi-retire from his successful career as an actor in 2000 as his condition worsened. For this reason, he established the Michael J. Fox Foundation to help advance Parkinson’s disease research through embryonic stem cell studies in an effort to find a cure for millions.

In an interview with Katie Couric, Fox explained his political advocacy: "I'm in this situation with millions of other Americans... and we have a right, if there are answers out there, to pursue those answers with the full support of our politicians".

Joining Oprah and Dr. Oz, Fox says that on the day the federal ban on embryonic stem cell research was lifted, "I was in Bhutan. I was in the Himalayas. So I wanted to get back, but the Himalayas are not that easy to get out of."

Fox further added, "It was absolutely crucial that this research be unfettered and allow us to go forward in a responsible way. But it really needed to happen - and candidate Obama made a commitment to it and President Obama came through on that commitment -- and it's an exciting day."

"I'm a dad. I'm a husband. I'm an activist. I'm a writer," Michael J. Fox said during the interview. "This is just one fact of my life. It doesn't define me."

To the stem cell community, Michael J. Fox is more than all of that – he is a hero. The Michael J. Fox Foundation has funded $142 million in research in an effort to find a cure for Parkinson’s and Fox has spent a majority of the past decade as an activist for stem cell research.

In 2006, Fox appeared in a taped interview on ABC's Good Morning America defending the Stem Cell Research Enhancement Act that would have expanded federal funding for stem cell research. The bill was not enacted, however, due to a veto by President George W. Bush.

More recently, Michael is featured in “The Accidental Advocate,” a compelling story about a father and daughter who track down the thinkers, the politicians, the crusaders and the naysayers in an effort to understand the potential of the science and why a political quagmire is stalling a cure.

Fox has been a true pioneer in the field of stem cell research and an inspiration to all who share his enthusiasm for the cause.




Bookmark and Share

Ron Paul Introduces Cures Can Be Found Act of 2009


Rep. Ron Paul [R-TX] introduced the Cures Can Be Found Act of 2009 again on March 19, 2009 to the House where it was referred to the House Committee on Ways and Means. If passed, the bill will amend the Internal Revenue Code of 1986 to provide credits against income tax for qualified stem cell research, the storage of qualified stem cells, and the donation of umbilical cord blood.

The amendments made by the bill will apply to taxable years beginning after December 31, 2008 and one provision offers a $2,000 tax credit for each qualified umbilical cord blood donation made. This is great news for the umbilical cord blood banking industry along with the entire stem cell sector as whole.

The latest revision to the Cures Can Be Found Act of 2009 was made on March 24, 2009 to allow credits only for donations to facilities that do not engage in research on stem cells derived from human embryos. This is yet another setback to embryonic stem cell research and will put many research facilities at a disadvantage if passed. This edit was obviously made to appease certain members of Congress in hopes of getting the bill passed.

Famous for starting the Ron Paul Revolution while running for President in 2007, Congressman Ron Paul has authored several pieces of legislation to address health care costs and make affordable health care available to more working families. The bills include increasing the amount and number of tax credits for the health insurance costs of taxpayers and their dependents as well waiving the employee portion of Social Security taxes for individuals who have been diagnosed with cancer or a terminal illness.




Dr. Robert Lanza’s book on Biocentrism will alter, and perhaps help you define, your universe



biocentrismrobert lanza

The whole of Western natural philosophy is undergoing a sea change again, forced upon us by the experimental findings of quantum theory.” – Robert Lanza


The next time you catch yourself on the verge of caving in to the pressures of everyday life, just take a moment to remember the world-renowned stem cell scientist Dr. Robert Lanza, Chief Scientific Officer of Advanced Cell Technology.

Lanza has not only managed to help revolutionize the world of science and modern medicine in an uphill battle that might save your life one day, but he even found the time to pen a book with astronomer Bob Berman on Biocentrism , a subject that challenges our traditional, outdated perceptions on life, time & space, and even death.

Biocentrism: How Life and Consciousness Are the Keys to Understanding the True Nature of the Universe is scheduled to be released May 5, 2009 and will be the latest, and one of the most anticipated, additions to the emerging field of quantum mechanics to date. If you have no idea what I just said, don’t worry, nobody knew what was going on the first time they heard that fancy collegiate term make its way into the conversation.

Well, maybe Dr. Lanza did, but he’s a genius.

If you have seen the mind-boggling movie What the Bleep!? - Down the Rabbit Hole starring Marlee Matlin or read The Secret by Rhonda Byrne, both huge hits, then you already know that fancy terms like “Biocentrism” and “quantum theory” are used to describe what is actually a relatively simple concept to understand (but not always to accept).

Quantum physics theorizes that life is the creator of the universe, not the other way around, and that we are more than just random mutations of flesh and bone sailing on a lonely voyage around the sun.

Everything that is happening to you right now in your life and where you stand has been drawn to you like a magnet by your thoughts, and you are continually defining your world and perception by the “frequency” you emit from those thoughts, whether you like it or not.

Simply put, if you think you are a loser and you feel like a loser, then you are a loser.

Conversely, when you are having feelings of gratitude and a sense of well being, you are drawing all of those good things into your life, because after all, it is YOUR world, and perception is reality.

There is a lot more to it than this and some studies may seem hard to believe at first (like how waves turn into particles merely from being observed and how what you do right now changes an event that already occurred in the past), but don’t worry, I will spare you from trying to explain the entire concept to you in this post. I’ll leave that job to the man who genetically modified pigmentation into albino chickens at the age of 14, and as he said in an interview with Discover Magazine regarding those seemingly impossible studies regarding time and space, “Those experiments are real. Get over it.”

However, I do strongly urge you to look into the movies (and books) I listed above (and below) if you haven’t done so already. Then you might understand why thousands of people, including myself, are making such an effort to recommend it to you in the first place, and why Dr. Robert Lanza would take time out of his hectic schedule as a stem cell scientist to publish a book about the quantum world and its infinite possibilities.

Disclaimer: Whether you walk away from the subject supporting it, condemning it, or decide to utilize only parts of it, it will change the way you perceive and think about things in the future.


You must first ask yourself one thing: Just how far down the rabbit hole do you want to go?







Obama: "This was the right thing to do and the ethical thing to do"

obamaconference
This is part of the full transcript from President Obama's news conference that took place on March 24, 2009 where Obama is questioned about stem cell research:

Q: In your remarks on stem cell research earlier this month, you talked about a majority consensus in determining whether or not this is the right thing to do, to federally fund embryonic stem cell research.

I'm just wondering, though, how much you personally wrestled with the morality or ethics of federally funding this kind of research, especially given the fact that science so far has shown a lot of progress with adult stem cells, but not a lot with embryonic?

OBAMA: OK. No, I think it's — I think it's a legitimate question. I, I wrestle with these issues every day.

As I mentioned to — I think in an interview a couple of days ago, by the time an issue reaches my desk, it's a hard issue. If it was an easy issue, somebody else would have solved it and it wouldn't have reached me.

Look, I believe that it is very important for us to have strong moral guidelines, ethical guidelines, when it comes to stem-cell research or anything that touches on, you know, the issues of possible cloning or issues related to, you know, the human life sciences.

I think those issues are all critical, and I've said so before.

I wrestle with it on stem cell; I wrestle with it on issues like abortion.

I think that the guidelines that we provided meet that ethical test. What we have said is that, for embryos that are typically about to be discarded, for us to be able to use those in order to find cures for Parkinson's or for Alzheimer's or, you know, all sorts of other debilitating diseases, juvenile diabetes, that, that it is the right thing to do.

And that's not just my opinion. That is the opinion of a number of people who are also against abortion.

Now, I am glad to see progress is being made in adult stem cells. And if the science determines that we can completely avoid a set of ethical questions or political disputes, then that's great.

I have, I have no investment in causing controversy. I'm happy to avoid it if that's where the science leads us. But what I don't want to do is predetermine this based on a very rigid ideological approach, and that's what I think is reflected in the executive order that I signed.

Q: I meant to ask — just to follow up — do you think that scientific consensus is enough to tell us what we can and cannot do?

OBAMA: No. I think there's, there's always an ethical and a moral element that has to be, be a part of this. And so, as I said, I, I don't take decisions like this lightly. They're ones that I take seriously, and, and I respect people who have different opinions on this issue.

But I think that this was the right thing to do and the ethical thing to do. And as I said before, my hope is, is that we can find a mechanism, ultimately, to cure these diseases in a way that gains 100 percent consensus. And we certainly haven't achieved that yet, but I think on balance this was the right step to take.




Obama questioned about stem cells 1 minute, 25 seconds into the video.

A full transcript of the conference can be found here.

Bookmark and Share

Advanced Cell Technology "Caveat Emptor" on Pinksheets

buyerbewareMarch 23, 2009 - Advanced Cell Technology, Inc. (ACTC) was labeled "Caveat Emptor" (Buyer Beware) on pinksheets.com.

"Buyer Beware. There is a public interest concern associated with the company, which may include a spam campaign, questionable stock promotion, known investigation of fraudulent activity committed by the company or insiders, regulatory suspensions, or disruptive corporate actions. During the time it is labeled Caveat Emptor, any stock that is not in the Current Information category will also have its quotes blocked on pinksheets.com."

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=ACTC#getFilings


Pink OTC Markets has discontinued the display of quotes on pinksheets.com for this security because it has been labeled Caveat Emptor (Buyer Beware) and because adequate current information has not been made available by the issuer of the securities. It has been labeled Caveat Emptor for one of the following reasons:

  • Questionable Promotion — The security is being promoted to the public, but adequate current information about the issuer has not been made available to the public.
  • Spam — The security is the subject of spam promotion having the effect of encouraging trading of the issuer's securities.
  • Investigation of Fraud — There is a known investigation of fraudulent activity involving the company, its securities or insiders.
  • Suspension/Halt — A Regulatory Authority has halted or suspended trading for public interest concerns (i.e. not a news or earning halt).
  • Disruptive Corporate Actions — The security or issuer is the subject of corporate actions, such as reverse mergers or serial stocks splits and name changes, without adequate current information being publicly available.
  • Unsolicited Quotes — The security has only been quoted on an unsolicited basis since it entered the public markets and the issuer has not made adequate current information available to the public.
  • Other Public Interest Concern — There is, in Pink OTC Markets' view, a public interest concern.
An e-mail sent to Pink Sheets regarding this issue returned the following response:

The specific reason would be as below:

Questionable Promotion - The security is being promoted to the public, but adequate current information about the issuer has not been made available to the public.
Please do not hesitate to contact me with any further questions you may have.

Best regards,

Khushboo Shrestha

Issuer Services

Pink OTC Markets Inc.
304 Hudson Street, 2nd Floor
New York, NY 10013
issuers@pinkotc.com
212-896-4420 W
212-896-5920 F

On a positive note, Advanced Cell Technology, Inc. (ACTC) was up 32% on Monday, March 23, 2009.

Family Guy Stem Cell Spoof



Peter Griffin (after leaving stem cell research lab): How long was I in there?

Police Officer: About 5 minutes.

Peter Griffin: WHY ARE WE NOT FUNDING THIS?

1.4.09: According to YouTube, "This video contains content from FOX, who has decided to block it."

Mitt Romney on stem cell research - March 19, 2009

mittromney
In an interview that aired March 19, 2009, Larry King asked former presidential candidate Mitt Romney if he supports "the stem cell thing," noting that Romney's wife has multiple sclerosis, a disease that some scientists think will be cured through stem cell research.

KING: Your wife has multiple sclerosis, a disease some scientists think will be cured through stem cell research. How is she doing?

ROMNEY: She's doing terrifically well. She's riding horses on a regular basis. She thinks that keeps her healthy and strong. And she's one of the few that has had very little progression from the disease. So I'm pleased and hopeful.

KING: Do you support the stem cell thing?

ROMNEY: I support stem cell research. I do not support creating new embryos for the purpose of taking away the life of that embryo, and taking stem cells from those embryos. There are a lot of better ways than getting stem cells from --

KING: Even though they're probably never going to be lives?

ROMNEY: If you create them in the laboratory, you're creating new life. And I wouldn't do that for the purpose of research, but there are fortunately much better ways of doing it, which has now been proven by scientists across the country.

KING: Do you think we're going to cure MS?

ROMNEY: I sure hope so. I think eventually we'll be curing most of the major diseases we know during our lifetimes. But when these things get cured, that's going to be a long time down the road.

KING: Your wife still as outspoken as always?

ROMNEY: She's the best, I'll tell you. I'm sure she's watching tonight. So, of course, outspoken and right.

KING: She says what she thinks?

ROMNEY: That's for sure.

KING: Always good seeing you.

ROMNEY: Thanks, Larry. Good to be with you.

A transcript for the entire interview can be found here.

Romney's response resembles the same one he gave in 2005 (Video) when he said "I believe stem cell research is important for our state and for our nation, and I also believe that there should be ethical guidelines drawn around the appropriate type of research."



Stem-cell discussion begins 3 minutes, 50 seconds into the video.

Bookmark and Share

Xiangzhong "Jerry" Yang

jerryyangI would like to remember the late Xiangzhong “Jerry” Yang, a great scientist who passed away on February 5, 2009 after a long battle with cancer at the age of 49.

Jerry escaped starvation in China as a child to become one of the most prestigious scientists in the United States. He is remembered for his scientific breakthroughs that included successfully cloning a farm animal for the first time in the United States and proving that early reports suggesting that clones would age prematurely were false.

However, Yang passed away before achieving his dream of cloning a human embryo that could be used for potentially lifesaving stem cells.

According to Dr. Robert Lanza, chief science officer at Advanced Cell Technology (ACTC), “[Yang] was a really great man who struggled to his last hours to better the world and to advance the scientific cause.”

Michael J. Fox

michaeljfox
Actor/Advocate Michael J. Fox is going back to the future, and this time, he wants to bring the American people with him on a quest to restore science and find a cure.

In 1991, Fox was diagnosed with Parkinson’s Disease and forced to semi-retire from his successful career as an actor in 2000 as his condition worsened. For this reason, he established the Michael J. Fox Foundation to help advance Parkinson ’s Disease research through embryonic stem cell studies in an effort to find a cure for millions.

In an interview with Katie Couric, Fox explained his political advocacy: "I'm in this situation with millions of other Americans... and we have a right, if there are answers out there, to pursue those answers with the full support of our politicians".

In 2006, Fox appeared in a taped interview on ABC's Good Morning America, defending the Stem Cell Research Enhancement Act that would have expanded federal funding for stem cell research. The bill was not enacted, however, due to a veto by President George W. Bush.

More recently, Michael is featured in “The Accidental Advocate,” a compelling story about a father and daughter who track down the thinkers, the politicians, the crusaders and the naysayers in an effort to understand the potential of the science and why a political quagmire is stalling a cure.


Fox has been a true pioneer in the field of stem cell research and an inspiration to all who share his enthusiasm for the cause.

James Alexander Thomson

James Alexander Thomson
James Alexander Thomson is an American developmental biologist who is best known for deriving the first human embryonic stem cell line. He serves as director of regenerative biology at the Morgridge Institute for Research in Madison, Wisconsin, and is a professor at the University of Wisconsin School of Medicine and Public Health. In 2007, he became an adjunct professor in the Molecular, Cellular, and Developmental Biology (MCDB) Department at the University of California, Santa Barbara. He is a member of the National Academy of Sciences. In 2008, TIME magazine, named him one of 100 of the most influential people in the world

Since joining the Wisconsin National Primate Research Center, Thomson has conducted pioneering work in the isolation and culture of non-human primate and human embryonic stem cells, undifferentiated cells that have the ability to become any of the cells that make up the tissues of the body. Thomson directed the group that reported the first isolation of embryonic stem cell lines from a non-human primate in 1995, work that led his group to the first successful isolation of human embryonic stem cell lines in 1998. On November 6, 1998, Science published the results of this research in an article titled Embryonic Stem Cell Lines Derived from Human Blastocysts.

On November 22, 2007, the New York Times reported that Thomson's laboratory had devised a method for modifying human skin cells in such a way that they appear to be embryonic stem cells without using a human embryo. This work was published in the journal Science in late 2007.

State Initiatives for Stem Cell Research

State Initiatives for Stem Cell Research


In Stem Cell Information [World Wide Web site]. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services, 2009 [cited Wednesday, March 11, 2009] Available at <http://stemcells.nih.gov/research/stateresearch>

Stem Cell Research Programs

Stem Cell Research Programs at Universities and Institutions


In Stem Cell Information [World Wide Web site]. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services, 2008 [cited Wednesday, March 11, 2009] Available at <http://stemcells.nih.gov/research/educresearch>

Stem Cell Glossary

Stem Cell Glossary


Adult (or somatic) stem cell
— An undifferentiated cell found in a differentiated tissue that can renew itself and differentiate (with certain limitations) to give rise to all the specialized cell types of the tissue from which it originated. It is important to note that scientists do not agree about whether or not adult stem cells may give rise to cell types other than those of the tissue from which they originate.

Astrocyte — a type of supporting (glial) cell found in the nervous system.

Blastocoel — The fluid-filled cavity inside the blastocyst of the developing embryo.

Blastocyst — A preimplantation embryo of about 150 cells produced by cell division following fertilization. The blastocyst is a sphere made up of an outer layer of cells (the trophoblast), a fluid-filled cavity (the blastocoel), and a cluster of cells on the interior (the inner cell mass).

Bone marrow stromal cells — A mixed population of stem cells found in bone marrow that does not give rise to blood cells but instead generates bone, cartilage, fat, and fibrous connective tissue.

Cell division — Method by which a single cell divides to create two cells. There are two main types of cell division: mitosis and meiosis.

Cell-based therapies — Treatment in which stem cells are induced to differentiate into the specific cell type required to repair damaged or destroyed cells or tissues.

Cell culture — Growth of cells in vitro in an artificial medium for experimental research.

Clone — Generate identical copies of a molecule, cell, or organism.

1. When it is used to refer to cells grown in a tissue culture dish, a clone is a line of cells that is genetically identical to the originating cell. This cloned line is produced by cell division (mitosis) of the originating cell.
2. The term clone may also be used to refer to an animal produced by somatic cell nuclear transfer (SCNT).

Cloning — See Clone.

Cord blood stem cells — See Umbilical cord blood stem cells.

Culture medium — The liquid that covers cells in a culture dish and contains nutrients to feed the cells. Medium may also include other growth factors added to produce desired changes in the cells.

Differentiation — The process whereby an undifferentiated embryonic cell acquires the features of a specialized cell such as a heart, liver, or muscle cell.

Directed differentiation — Manipulating stem cell culture conditions to induce differentiation into a particular cell type.

DNA — Deoxyribonucleic acid, a chemical found primarily in the nucleus of cells. DNA carries the instructions or blueprint for making all the structures and materials the body needs to function.

Ectoderm — Outermost germ layer of cells derived from the inner cell mass of the blastocyst; gives rise to the nervous system, sensory organs, skin, and related structures.

Embryo — In humans, the developing organism from the time of fertilization until the end of the eighth week of gestation, when it is called a fetus.

Embryoid bodies — Rounded collections of cells that arise when embryonic stem cells are cultured in suspension. Embryoid bodies contain cell types derived from all 3 germ layers.

Embryonic germ cells — Pluripotent stem cells that are derived from early germ cells (those that would become sperm and eggs). Embryonic germ cells (EG cells) are thought to have properties similar to embryonic stem cells.

Embryonic stem cells — Primitive (undifferentiated) cells derived from a 5-day preimplantation embryo that have the potential to become a wide variety of specialized cell types.

Embryonic stem cell line — Embryonic stem cells, which have been cultured under in vitro conditions that allow proliferation without differentiation for months to years.

Endoderm — Innermost layer of the cells derived from the inner cell mass of the blastocyst; it gives rise to lungs, other respiratory structures, and digestive organs, or generally "the gut".

Enucleated — A cell with its nucleus removed.

Feeder layer — Cells used in co-culture to maintain pluripotent stem cells. For human embryonic stem cell culture, typical feeder layers include mouse embryonic fibroblasts (MEFs) or human embryonic fibroblasts that have been treated to prevent them from dividing.

Fertilization — The joining of the male gamete (sperm) and the female gamete (egg).

Fetus — A developing human from approximately eight weeks after conception until the time of its birth.

Gamete — An egg (in the female) or sperm (in the male) cell. See also Somatic cell.

Gene — A functional unit of heredity that is a segment of DNA found on chromosomes in the nucleus of a cell. Genes direct the formation of an enzyme or other protein.

Germ layers — Fertilization of an egg stimulates cell division, and the resulting cells are organized into three different layers, called germ layers. The three layers are the ectoderm, the mesoderm, and the endoderm.

Hematopoietic stem cell — A stem cell that gives rise to all red and white blood cells and platelets.

Human embryonic stem cell (hESC) — A type of pluripotent stem cell derived from the inner cell mass (ICM) of the blastocyst.

Induced pluripotent stem cells — Adult cells reprogrammed to an embryonic stem cell–like state by being forced to express factors important for maintaining the "stemness" of embryonic stem cells (ESCs). Mouse iPSCs were first reported in 2006 (Takahashi and Yamanaka), and human iPSCs were first reported in late 2007 (Takahashi et al. and Yu et al.). Mouse iPSCs demonstrate important characteristics of pluripotent stem cells, including expressing stem cell markers, forming tumors containing cells from all three germ layers, and being able to contribute to many different tissues when injected into mouse embryos at a very early stage in development. Human iPSCs also express stem cell markers and are capable of generating cells characteristic of all three germ layers. Scientists are actively comparing iPSCs and ESCs to identify important similarities and differences.

In vitro — Latin for "in glass"; in a laboratory dish or test tube; an artificial environment.

In vitro fertilization — A technique that unites the egg and sperm in a laboratory, instead of inside the female body.

Inner cell mass (ICM) — The cluster of cells inside the blastocyst. These cells give rise to the embryo and ultimately the fetus. The ICM cells are used to generate embryonic stem cells.

Long-term self-renewal — The ability of stem cells to renew themselves by dividing into the same non-specialized cell type over long periods (many months to years) depending on the specific type of stem cell.

Mesenchymal stem cells — Cells from the immature embryonic connective tissue. A number of cell types come from mesenchymal stem cells, including chondrocytes, which produce cartilage.

Meiosis — Cell division of a gamete to reduce the chromosomes within it to half the normal number. This is to ensure that fertilization restores the full number of chromosomes rather than causing aneuploidy, or an abnormal number of chromosomes.

Mesoderm — Middle layer of a group of cells derived from the inner cell mass of the blastocyst; it gives rise to bone, muscle, connective tissue, kidneys, and related structures.

Microenvironment — The molecules and compounds such as nutrients and growth factors in the fluid surrounding a cell in an organism or in the laboratory, which play an important role in determining the characteristics of the cell.

Mitosis — Cell division that allows a population of cells to increase its numbers or to maintain its numbers.

Multipotent — Ability of a single stem cell to develop into more than one cell type of the body. See also pluripotent and totipotent.

Neural stem cell — A stem cell found in adult neural tissue that can give rise to neurons and glial (supporting) cells. Examples of glial cells include astrocytes and oligodendrocytes.

Neurons — Nerve cells, the structural and functional unit of the nervous system. A neuron consists of a cell body and its processes—an axon and one or more dendrites. Neurons function by starting and conducting impulses. Neurons transmit impulses to other neurons or cells by releasing neurotransmitters at synapses.

Oligodendrocyte — A supporting cell that provides insulation to nerve cells by forming a myelin sheath (a fatty layer) around axons.

Parthenogenesis — Artificial activation of an egg in the absence of a sperm; the egg is "tricked" into behaving as if it has been fertilized.

Passage — A round of cell growth and proliferation in cell culture.

Plasticity — The ability of stem cells from one adult tissue to generate the differentiated cell types of another tissue.

Pluripotent — Ability of a single stem cell to give rise to all of the various cell types that make up the body. Pluripotent cells cannot make so-called "extra-embryonic" tissues such as the amnion, chorion, and other components of the placenta. Scientists demonstrate pluripotency by providing evidence of stable developmental potential, even after prolonged culture, to form derivatives of all three embryonic germ layers from the progeny of a single cell and to generate a teratoma after injection into an immunosuppressed mouse.

Polar Body — A polar body is a structure produced when an early egg cell, or oogonium, undergoes meiosis. In the first meiosis, the oogonium divides its chromosomes evenly between the two cells but divides its cytoplasm unequally. One cell retains most of the cytoplasm, while the other gets almost none, leaving it very small. This smaller cell is called the first polar body. The first polar body usually degenerates. The ovum, or larger cell, then divides again, producing a second polar body with half the amount of chromosomes but almost no cytoplasm. The second polar body splits off and remains adjacent to the large cell, or oocyte, until it (the second polar body) degenerates. Only one large functional oocyte, or egg, is produced at the end of meiosis.

Preimplantation — With regard to an embryo, preimplantation means that the embryo has not yet implanted in the wall of the uterus. Human embryonic stem cells are derived from preimplantation stage embryos fertilized outside a woman's body (in vitro).

Proliferation — Expansion of cells by the continuous division of single cells into two identical daughter cells.

Regenerative medicine — A treatment in which stem cells are induced to differentiate into the specific cell type required to repair damaged or destroyed cell populations or tissues. (See also cell-based therapies).

Reproductive cloning — The goal of reproductive cloning is to create an animal being identical to the animal that donated the somatic cell nucleus. The embryo is implanted in a uterus and develops into a live being. The first animal to be created by reproductive cloning was Dolly the sheep, born at the Roslin Institute in Scotland in 1996. See also Somatic cell nuclear transfer (SCNT).

Signals — Internal and external factors that control changes in cell structure and function.

Somatic cell — any body cell other than gametes (egg or sperm). See also Gamete.

Somatic cell nuclear transfer (SCNT) — A technique that combines an enucleated egg (nucleus removed) and the nucleus of a somatic cell to make an embryo. SCNT can be used for therapeutic or reproductive purposes, but the initial stage that combines an enucleated egg and a somatic cell nucleus is the same. See also therapeutic cloning and reproductive cloning.

Somatic stem cells — Non-embryonic stem cells that are not derived from gametes (egg or sperm cells).

Stem cells — Cells with the ability to divide for indefinite periods in culture and to give rise to specialized cells.

Stromal cells — Non-blood cells derived from blood organs, such as bone marrow or fetal liver, which are capable of supporting growth of blood cells in vitro. Stromal cells that make the matrix within the bone marrow are also derived from mesenchymal stem cells.

Subculturing — Transferring cultured cells, with or without dilution, from one culture vessel to another.

Surface markers — Proteins on the outside surface of a cell that are unique to certain cell types, which are visualized using antibodies or other detection methods.

Teratoma — Scientists verify that they have established a human embryonic stem cell (hESC) line by injecting putative stem cells into mice with a dysfunctional immune system. Since the injected cells cannot be destroyed by the mouse's immune system, they survive and form a multi-layered benign tumor called a teratoma. Even though tumors are not usually a desirable outcome, in this test, the teratomas serve to establish the ability of a stem cell to give rise to all cell types in the body. This is because the teratomas contain cells derived from each of the three embryonic germ layers.

Therapeutic cloning — The goal of therapeutic cloning is to create cells that exactly match a patient. By combining a patient's somatic cell nucleus and an enucleated egg, a scientist may harvest embryonic stem cells from the resulting embryo that can be used to generate tissues that match a patient's body. This means the tissues created are unlikely to be rejected by the patient's immune system. See also Somatic cell nuclear transfer (SCNT).

Totipotent — A totipotent stem cell can give rise to all the cell types that make up the body plus all of the cell types that make up the extraembryonic tissues such as the placenta. (See also Pluripotent and Multipotent).

Transdifferentiation — The process by which stem cells from one tissue differentiate into cells of another tissue. See also Plasticity.

Trophectoderm — a term used to refer to trophoblast cells in mice.

Trophoblast — The extraembryonic tissue responsible for implantation, developing into the placenta, and controlling the exchange of oxygen and metabolites between mother and embryo.

Umbilical cord blood stem cells — stem cells collected from the umbilical cord at birth that can produce all of the blood cells in the body (hematopoietic). Cord blood is currently used to treat patients who have undergone chemotherapy to destroy their bone marrow due to cancer or other blood-related disorders.

Undifferentiated — A cell that has not yet generated structures or manufactured proteins characteristic of a specialized cell type.

February 2009: Top 5 Stem Cell Blog Entries

The month of February was a tense one for the stem cell community as the nation waited for some sort of acknowledgment from President Obama.

It never came.

As a result, investors lost money, advocates lost a bit of hope, and potential patients lost a second chance at life.

I present you with the top five blog entries regarding stem cells for the month of February:


5. Was Yoda a Stem Cell Patient?

A clever and humorous story from StemCellTracker.com suggesting that at the age of 900, Yoda (from Star Wars) was undoubtedly a stem cell recipient.

The entry goes on to suggest that Yoda's famous quote was really a reference to the stem cell debate:

"Fear is the path to the dark side. Fear leads to anger. Anger leads to hate. Hate leads to suffering."


4. Future Stem Cell Policy in the U.S.

Jonathan Slack, director of the Stem Cell Institute at the University of Minnesota, offers an insight to what will happen for stem cell research if/when the federal funding ban is lifted.


3. Stem Cell Company Stocks - Updated 2/25/09

This blog's goal is to discuss the ways of making money trading stem cell company stocks, and is so far doing a damn good job in the analysis department.

This February update offers insight to the top performing and worst performing stem cell stocks, and even discusses possible catalysts for why trends, price drops, and surges are happening.


2. How to Invest in Stem Cell Companies

eHow.com member paulgochs provides a "how-to" on investing in stem cell companies. The entry provides 14 steps one should take if they are going to invest in stem cell companies with any success.

These steps include figuring out how much debt a company is in, watching management closely, and reviewing SEC reports, to name a few.

Are stem cell investments too risky for you? Step 14 suggests looking at companies that provide products and services to the stem cell research laboratories.


1. Obama silent about federal funding of Embryonic Stem Cell Research


An entry that not only criticizes Obama's failure to mention stem cells in his widely talked about "Tuesday Speech," but offers insight and questions beyond that.

How much money is expected to flow into stem cell companies if the ban is lifted? Which companies will see this income?

Of course, the answers to these questions are what make it such a great entry. It suggests that publicly traded companies will not see much money from a federal ban reversal because the funding of scientific research at the federal level is managed by the National Institutes of Health, and a majority of NIH funding goes to academia, not commercial entities.

Before killing every investor's dream, the article explains how companies can still benefit indirectly if the federal dollars following into academia spur private investments.

Honorable Mention:

Cell Therapy Group & BioBusiness.TV collaborate to bring online coverage of cell therapy content from the 2009 Phacilitate Cell & Gene Therapy Forum

Lee Buckler's blog, CellTherapyBlog, provided some real stem cell reporting by providing coverage of the 2009 Phacilitate Cell & Gene Therapy Forum (say that 5 times real fast).

The article provides highlights, a review, interviews, Mash Ups, and 60 second pitches from the event.
_________________________________

What did you think of these entries? Comment and let the stem cell community know.

The month of March is already turning out to be very interesting for stem cell talk!

Stay tuned...

Privacy Policy


This site uses third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

The DoubleClick DART cookie is used by Google in the ads served on publisher websites displaying AdSense for content ads. When users visit an AdSense publisher's website and either view or click on an ad, a cookie may be dropped on that end user's browser. The data gathered from these cookies will be used to help AdSense publishers better serve and manage the ads on their site(s) and across the web.

Users may opt out of the use of the DART cookie by visiting the Google ad and content network privacy policy.

Any personal information gathered (e-mail addresses from subscriptions, personal details from inquiries via e-mail, etc.) will never be sold or given away by the webmaster of this site.